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Inflammation may be linked to the pathogenesis of colorec-
tal cancer. However, two conflicting observational results were
recently reported on the relationship between the inflammatory
marker C-reactive protein (CRP) and the risk of colorectal
cancer. Few epidemiologic studies have examined the associa-
tion between inflammatory markers and the risk of colorectal
cancer. We prospectively examined the mortality and incidence
risk for colon and rectal cancers among 424,419 Koreans
(108,907 men and 315,512 women). The subjects were 40 to
95 years of age and from the Korean Cancer Prevention Study
(KCPS) cohort. All subjects received medical examination
from the National Health Insurance Corporation in 1993 and
1995. The maximum follow-up period was 10 years, and the
follow-up periods began in January 1, 1994 and ended in
December 31, 2003. An elevated white blood cell count
(WBC) was associated with a higher mortality risk of colon
cancer (highest versus lowest quartile: men, 1.55, 95% CI
1.10-2.18, p for trend = 0.0014; women, 1.51, 95% CI 1.12-
2.03, p for trend = 0.0049). Similarly, an elevated WBC was
associated with a higher incidence risk of colon cancer
(highest versus lowest quartile: men, 1.38, 1.09-1.76, p for
trend = 0.0017; women, 1.46, 95% CI 1.20-1.78, p for trend=
0.0003). A positive linear trend was also observed in non-
smokers. There was no significant association between WBC
and the risk of rectal cancer. Our findings demonstrate that an
elevated WBC is associated with an increase in both the mor-
tality and incidence rates of colon cancer. These results support
our hypothesis that inflammation increases the risk of colon
cancer.
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INTRODUCTION
The proportion of colorectal cancer has been
gradually increasing during the past several dec-
ades in Korea. In 1980, when the Central Cancer
Registry began, colorectal cancers accounted for
5.8% of total cancers.1 In 1990 and 2002, this figure
increased to 6.9% and 11.2%, respectively. With
estimates of 11,000 new cases annually, colorectal
cancer is the fourth most common cancer and the
fourth leading cause of cancer-related deaths in
Korea.1,2 In 1983, the death rate of colorectal can-
cers accounted for 1.6 per 100,000 person-years,
and rapidly increased to 10.6 per 100,000 person-
years in 2002.2
Considerable studies have examined factors that
influence the development of colorectal cancer.
Family histories of colorectal cancer,3 obesity,4
animal fat intake,
5
alcohol,
6
cigarette smoking,
7
physical inactivity,8 and insulin resistance9 have
been regarded as predisposing factors of colo-
rectal cancer.
Increasing evidence suggests that inflammation
may be linked to the pathogenesis of colorectal
cancer. Many studies have suggested a relation-
ship between colorectal cancer and chronic in-
flammation. The risk of colorectal cancer increases
in patients with long-standing inflammatory bowel
diseases.10 In addition, several studies have con-
sistently shown a risk reduction for the incidence
of colorectal adenoma and cancer among regular
and prolonged users of aspirin or other non-
steroidal anti-inflammatory drugs (NSAIDs).
11,12
However, two conflicting observational results
were recently reported on the relationship between
the inflammatory marker C-reactive protein (CRP)
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and the risk of colorectal cancer. A nested case-
control study showed that individuals with CRP
concentrations in the highest quartile had a signi-
ficantly higher risk for the incidence of colon
cancer compared with individuals in the lowest
quartile.13 In contrast, another prospective study
demonstrated that an elevated plasma CRP level
was not a predictor of colorectal cancer but was
merely increased after the onset of colorectal
cancer.14
White blood cell count (WBC) is another marker
of nonspecific inflammation and was analyzed in
this study to examine its relationship with the risk
of colorectal cancer. We hypothesized that an
elevated WBC is associated with the risk of colo-
rectal cancer. Furthermore, WBCs and CRP levels
tend to be chronically elevated in smokers. There-
fore, we also hypothesized that the association
between inflammation and risk of colon cancer
would be independent of smoking.15,16 To test
these hypotheses, we prospectively determined
the risk of colorectal cancer associated with WBC.
MATERIALS AND METHODS
Study population
The Korean Cancer Prevention Study (KCPS) is
a prospective cohort study that was designed to
assess risk factors for mortality, incidence, and
hospital admission for cancer. The KCPS cohort
was composed of government employees, teachers,
and their dependents insured by the Korean
Medical Insurance Corporation from 1992 through
1995. The subjects had at least one medical ex-
amination and completed a questionnaire during
that period. The KCPS cohort includes 1,329,525
Koreans (846,907 men and 482,618 women) from
30 to 95 years old who met the above selection
criteria. The current analysis was limited to the
446,878 participants who were the insured workers'
family dependents in 1993 and 1995. Insured
workers were excluded from this study popu-
lation because there was no WBC record in their
examinations. The 3,703 participants who reported
a history of any cancer at enrollment and 1,483
participants who died of cancer before the start of
follow-up were also excluded. Additionally,
17,273 participants with missing data on any cova-
riate information were excluded from the study.
After these exclusions, 424,419 participants (108,907
men and 315,512 women) who received medical
examination in 1993 and 1995 were included in
the analyses.
Data collection
Medical examinations were performed according
to a standard procedure and conducted by the
medical staffs at local hospitals. In the 1993 and
1995 questionnaires, participants were asked
about smoking habits and other health behaviors.
Participants were also asked if they were currently
being treated for cancer or other diseases. If so,
they were asked for the date of diagnosis. The
completed questionnaires were reviewed by
trained staff and then entered into a database. The
data were also checked and cleaned again during
the analysis. Body mass index (BMI, kg/m2) was
calculated as the ratio of weight (kg) divided by
height squared (m2). WBC, plasma glucose, and
total cholesterol were measured under fasting
conditions for routine clinical purposes. Each
hospital had internal and external quality control
procedures directed by the Korean Association of
Laboratory Quality Control. Alcohol consumption
per day was categorized as follows: no drinking
(0 g), light drinking (1-29.9 g), and moderate to
heavy drinking (30 g or more). Diabetes was
defined as self-reported history of the disorder or
when a fasting plasma glucose level was 126
mg/dL. Hypertension was defined as
self-reported history of the disorder or when
systolic blood pressure was 140 mmHg or
diastolic blood pressure 90 mmHg.
The maximum follow-up period was 10 years,
from January 1, 1994 to December 31, 2003. The
exact dates of completion of the survey form were
not recorded. Consequently, follow-up accrual
began January 1 of the calendar year and ended
in the year in which the survey form was com-
pleted. Subjects who completed a survey but died
in the same calendar year were excluded.
Because the study involved routinely collected
medical data, it was not necessary to obtain
individual participant consent. The study was
approved by both Institutional Review Boards
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of Yonsei University and the Johns Hopkins
Bloomberg School of Public Health.
Cancer outcomes
The primary outcomes were mortality and
incidence risk of colon and rectal cancers based on
the National Cancer Registry data and hospitali-
zation records. Although Korea has a National
Cancer Registry, reporting may not have been
complete during the follow-up period. Thus,
hospital administration files were used to identify
the date of diagnosis. Therefore, incident cancer
cases were coded as occurring either upon regis-
tration with the National Cancer Registry or upon
hospital admission due to cancer diagnosis. Mor-
tality was ascertained from death certificates. A
computerized search of death certificate data from
the National Statistical Office in Korea was per-
formed using the unique identification number
assigned at birth. Causes of death were assigned
at the hospitals by trained abstractors. The an-
alysis was limited to those deaths assigned to the
10th revision of the International Classification of
Diseases (ICD-10): C18, malignant neoplasm of
colon; C19, malignant neoplasm of rectosigmoid
junction; and C20, malignant neoplasm of rectum.
Statistical analysis
Based on WBC at enrollment, Chi-square tests
and one-way analyses of variance were used to
analyze the statistical differences among charac-
teristics of the study participants. Categorization
of WBC into quartiles was based on the distribu-
tion of WBC among the study participants aged
40 to 95 years at baseline. Therefore, WBC (cells/
L) quartiles were categorized asμ 5500, 5501-
6500, 6501-7600, and > 7600. In all primary an-
alyses, the WBC quartile of 5500 cells/ L wasμ
used as the reference group.
Age-adjusted death and incidence rates were
calculated for each WBC quartile and were di-
rectly standardized to the age distribution of the
Korean population in 1995. Cox proportional
hazards regression models were used to compute
hazard ratios (HR) and their 95% confidence
intervals (CIs), while adjusting for other potential
risk factors. Cox models were also used to assess
the trends in risk with quartiles of WBC as a con-
tinuous variable. To exclude sub-clinical disease at
baseline, we conducted analysis for the incidence
of colon cancer after excluding cases that occurred
within 2 years of follow-up. The association
between WBC and the incidence of colon cancer
was also assessed by stratification according to
smoking status in order to confirm that the asso-
ciation was independent of the effects of smoking
on WBC.
All analyses were conducted using SAS statis-
tical software, version 8.1 (SAS Institute Inc, Cary,
NC, USA). All statistical tests were two- sided,
and statistical significance was determined at p <
0.05.
RESULTS
The baseline characteristics of the study popu-
lation (according to WBC quartiles) are shown in
Tables 1 and 2. Increased mean BMI, systolic and
diastolic blood pressure, fasting plasma glucose
concentration, total cholesterol concentration,
amount of daily alcohol consumption, smoking
duration, and frequency of meat intake all cor-
related with higher WBC. The percentages of
hypertension, diabetes, and current smokers also
correlated with WBC. Regular exercise was in-
versely associated with WBC.
During the 10 year follow-up, 25,458 and 21,482
deaths occurred among men and women, respec-
tively. The multivariate adjusted HRs for all-cause
mortality in the highest WBC quartile were 1.15
and 1.22 compared with the reference category in
men (95% CI 1.11-1.20, p for trend < 0.0001) and
women (95% CI 1.18-1.27, p for trend < 0.0001),
respectively (Tables 3, 4).
For men, there were 9,010 deaths from all can-
cers, including 310 from colon cancer and 229
from rectal cancer, during the 10 year follow-up.
For women, there were 5,871 deaths from all
cancers, including 352 from colon cancer and 237
from rectal cancer. Tables 3 and 4 show that HRs
for mortality from colon cancer increase with
WBC quartiles among men and women. In men,
the multivariate adjusted HRs for all-cause mor-
tality in the highest WBC quartile were 1.33 (95%
CI 1.03-1.72, p for trend = 0.0031) for colorectal
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cancer and 1.55 (95% CI 1.10-2.18, p for trend
=0.0014) for colon cancer, compared with the
reference category (Table 3). The higher mortality
risk associated with higher WBC quartiles was
also observed for colon cancer in women (highest
versus lowest quartile: HR 1.51, 95% CI 1.12-2.03,
p for trend = 0.0049) (Table 4). In contrast to colon
cancer, there was no significant difference in mor-
tality risk for rectal cancer between the highest
quartile and the lowest quartile in men or women.
The incidences of colon cancer during the 10
year follow-up were 604 among men and 838
among women. The trend of colorectal cancer in-
cidence was generally similar to the mortality risk
of colorectal cancer. Tables 5 and 6 show that HRs
for colon cancer incidence increase with WBC
quartile. The multivariate adjusted HRs for in-
cidence in the highest WBC quartile were 1.23
(95% CI 1.03-1.47, p for trend = 0.0030) for colorec-
tal cancer and 1.38 (95% CI 1.09-1.76, p for trend
Table 1. Baseline Characteristics of WBC Quartiles in Male Participants*
Quartiles of WBC, cells/ Lμ
p value5500
(n = 18,611)
5501 - 6500
(n = 24,567)
6501 - 7600
(n = 28,018)
> 7600
(n = 37,711)
Age, year 63.3 (8.8) 62.6 (8.7) 62.4 (8.5) 61.8 (8.5) < 0.0001
Body mass index, kg/m2 22.2 (2.8) 22.6 (2.9) 22.7 (2.9) 22.8 (2.9) < 0.0001
Systolic blood pressure, mmHg 128.0 (20.5) 129.4 (21.0) 130.0 (21.0) 130.2 (21.1) < 0.0001
Diastolic blood pressure, mmHg 81.6 (13.0) 82.3 (13.1) 82.8 (13.3) 82.9 (13.2) < 0.0001
Fasting plasma glucose, mg/dL 95.9 (31.1) 96.5 (32.2) 96.6 (31.6) 97.6 (34.6) < 0.0001
Total cholesterol, mg/dL 183.5 (37.4) 188.8 (37.9) 191.3 (6.0) 194.0 (39.6) < 0.0001
Alcohol consumption, g/day
0 41.4 39.0 38.2 36.9 < 0.0001
1 - 29.9 57.9 60.3 61.2 62.4
30 0.7 0.7 0.7 0.7
Smoking duration, years 29.4 (18.2) 30.8 (1.6) 31.8 (17.2) 33.7 (16.1) < 0.0001
Smoking status, % < 0.0001
Non smoker 26.2 22.5 20.1 15.6
Ex-smoker 31.0 29.0 26.7 22.5
Current smoker 42.7 48.5 53.2 61.9
Regular exercise, % 33.3 32.2 31.1 29.1 < 0.0001
Meat intake, times /week, % < 0.0001
Nearly none 46.8 46.0 45.3 44.5
1 - 2 30.0 29.4 29.4 29.2
3 23.2 24.6 25.3 26.3
Hypertension, % 33.4 35.9 36.9 37.4 < 0.0001
Diabetes, % 8.0 8.4 8.6 9.6 < 0.0001
*Data are expressed as mean (SD) unless otherwise indicated.
Hypertension was defined as SBP 140 mmHg, DBP 90 mmHg, or history of the disorder.
Diabetes was defined as fasting plasma glucose level of at least 126 mg/dL (7.0 mmol/L) or a history of the disorder.
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= 0.0017) for colon cancer, compared with the re-
ference category in men (Table 6). The higher
incidence risk associated with an increased WBC
was also seen for colon cancer in women (highest
versus lowest quartile: HR 1.46, 95% CI 1.20-1.78,
p for trend = 0.0003) (Table 6). There was no sig-
nificant difference in incidence risk for rectal
cancer between the highest quartile and the lowest
quartile among men or women. A total 145 cases
of colon cancer occurred within 2 years of follow-
up, 61 cases for men and 84 cases for women. Even
after excluding these cases that occurred within 2
years of follow-up, the association between WBC
and colon cancer was sustained. The multivariate
adjusted HRs for incidence of colon cancer in the
highest WBC quartile were 1.34 (95% CI 1.04-1.73,
p for trend = 0.0058) in men and 1.41 (95% CI 1.14-
1.73, p for trend = 0.0058) in women.
Table 2. Baseline Characteristics of WBC Quartiles in Female Participants*
Quartile of WBC, cells/ Lμ
p value5500
(n = 90,790)
5501 - 6500
(n = 84,260)
6501 - 7600
(n = 73,364)
> 7600
(n = 67,098)
Age, year 53.9 (9.7) 54.5 (9.9) 55.0 (10.0) 55.8 (10.4) < 0.0001
Body mass index, kg/m2 23.5 (3.0) 23.9 (3.1) 24.2 (3.1) 24.4 (3.3) < 0.0001
Systolic blood pressure, mmHg 123.2 (19.9) 125.3 (20.7) 126.5 (21.1) 128.2 (21.7) < 0.0001
Diastolic blood pressure, mmHg 79.2 (12.9) 80.5 (13.3) 81.1 (13.4) 82.0 (13.6) < 0.0001
Fasting plasma glucose, mg/dL 90.7 (21.6) 92.4 (25.4) 93.8 (27.8) 96.3 (32.8) < 0.0001
Total cholesterol, mg/dL 194.5 (38.2) 199.2 (38.9) 201.7 (39.7) 205.6 (41.1) < 0.0001
Alcohol consumption, g/day, % < 0.0001
0 87.8 86.6 85.8 85.0
1 - 29.9 12.2 13.4 14.2 15.2
30 0.0 0.0 0.0 0.0
Smoking duration, years 4.8 (9.5) 5.8 (10.8) 6.7 (11.7) 8.3 (13.2) < 0.0001
Smoking status, % < 0.0001
Non smoker 94.0 92.2 90.6 87.7
Ex-smoker 2.3 2.8 3.1 3.6
Current smoker 3.8 5.1 6.3 8.7
Regular exercise, % 19.2 18.6 18.3 17.3 < 0.0001
Meat intake, times /week, % < 0.0001
Nearly none 24.9 24.8 24.7 24.3
1 - 2 60.3 60.3 60.2 60.0
3 14.8 14.9 15.1 15.7
Hypertension, % 23.9 27.9 30.1 33.2 < 0.0001
Diabetes, % 3.6 5.0 6.2 8.6 < 0.0001
*Data are expressed as mean (SD) unless otherwise indicated.
Hypertension was defined as SBP 140 mmHg, DBP 90 mmHg, or history of the disorder.
Diabetes was defined as fasting plasma glucose level of at least 126 mg/dL (7.0 mmol/L) or a history of the disorder.
Table 3. Age-adjusted Mortality Rate per 100,000 Person-years and Hazard Ratios for All Causes, All Cancers, Colon
Cancer, and Rectal Cancer by WBC Quartile in Men, 1994-2003*
Quartile of WBC, cells/ Lμ
p value
for trend
5500
(n = 18,611)
5501 - 6500
(n = 24,567)
6501 - 7600
(n = 28,018)
> 7600
(n = 37,711)
All causes, n 4,307 5,499 6,377 9,275
Death rate 1513.3 1246.7 1306.1 1484.3
HR 1.00 0.99 (0.96 - 1.04) 1.02 (0.98 - 1.06) 1.15 (1.11 - 1.20) < 0.0001
All cancers, n 1,618 1,962 2,196 3,237
Death rate 572.1 466.6 459.6 514.8
HR 1.00 0.93 (0.87 - 0.99) 0.90 (0.85 - 0.96) 1.01 (0.95 - 1.07) 0.3820
Colorectal cancer, n 86 102 134 217
Death rate 28.6 20.3 24.5 31.3
HR 1.00 0.91 (0.68 - 1.21) 1.06 (0.81-1.40) 1.33 (1.03 - 1.72) 0.0031
Colon cancer, n 47 56 75 132
Death rate 19.7 8.6 12.6 20.3
HR 1.00 0.94 (0.64 - 1.40) 1.10 (0.76 - 1.59) 1.55 (1.10 - 2.18) 0.0014
Rectal cancer, n 39 46 59 85
Death rate 8.9 11.7 11.9 11.0
HR 1.00 0.90 (0.58 - 1.39) 1.07 (0.71 - 1.61) 1.22 (0.83 - 1.80) 0.1555
CI, confidence interval; HR, hazard ratio.
* Participants with any of the following features at study entry were excluded: missing data on leukocyte count, existing cancer, and
missing data on questionnaire.
The rate per 100,000 person-years is given, standardized to the age distribution of men in the 1995 Korean national population.
The Cox proportional hazards model was adjusted for age, BMI, total cholesterol, smoking status, regular exercise, alcohol consumption
per day (none, 0 - 29.9 g/day, 30 g/day), frequency of meat intake per week (nearly none, 1 - 2, 3), hypertension, and diabetes.
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Table 4. Age-adjusted Mortality Rate per 100,000 Person-years and Hazard Ratios for All Causes, All Cancers, Colon
Cancer, and Rectal Cancer by WBC Quartile in Women, 1994-2003*
Quartile of WBC, cells/ Lμ
p value
for trend5500
(n = 90,790)
5501 - 6500
(n = 84,260)
6501 - 7600
(n = 73,364)
> 7600
(n = 67,098)
All causes, n 5,134 5,220 5,159 5,969
Death rate 622.9 632.6 677.3 791.5
HR 1.00 1.01 (0.98 - 1.05) 1.06 (1.02 - 1.11) 1.22 (1.18 - 1.27) <0.0001
All cancers, n 1,657 1,411 1,429 1,374
Death rate 191.5 165.7 185.0 183.7
HR 1.00 0.91 (0.85 - 0.98) 1.01 (0.94 - 1.08) 0.99 (0.93 - 1.07) 0.6429
Colorectal cancer, n 155 146 137 151
Death rate 18.2 17.0 17.8 19.6
HR 1.00 0.95 (0.75 - 1.19) 1.00 (0.79 - 1.26) 1.11 (0.88 - 1.40) 0.3408
Colon cancer, n 86 80 83 103
Death rate 10.1 9.4 10.9 13.2
HR 1.00 1.03 (0.76 - 1.41) 1.18 (0.87 - 1.61) 1.51 (1.12 - 2.03) 0.0049
Rectal cancer, n 69 66 54 48
Death rate 8.1 7.6 6.9 6.4
HR 1.00 0.98 (0.69 - 1.39) 0.92 (0.64 - 1.32) 0.79 (0.54 - 1.16) 0.2179
CI, confidence interval; HR, hazard ratio.
*Participants with any of the following features at study entry were excluded: missing data on leukocyte count, existing cancer, and
missing data on questionnaire.
The rate per 100,000 person-years is given, standardized to the age distribution of women in the 1995 Korean national population.
The Cox proportional hazards model was adjusted for age, BMI, total cholesterol, smoking status, regular exercise, alcohol consumption
per day (none, 0 - 29.9 g/day, 30 g/day), frequency of meat intake per week (nearly none, 1 - 2, 3), hypertension, and diabetes.
Table 6. Age-adjusted Incidence Rate per 100,000 Person-years and Hazard Ratios for All Cancers, Colon Cancer, and
Rectal Cancer by WBC Quartile in Women, 1994-2003*
Quartile of WBC, cells/ Lμ
p value
for trend
5500
(n = 90,790)
5501 - 6500
(n = 84,260)
6501 - 7600
(n = 73,364)
> 7600
(n = 67,098)
All cancers, n 3,557 3,122 2,799 2,626
Incidence rate 458.9 423.8 431.9 435.8
HR 1.00 0.99 (0.94 - 1.04) 1.00 (0.95 - 1.06) 1.02 (0.97 - 1.08) 0.3789
Colorectal cancer, n 405 400 353 371
Incidence rate 52.1 53.1 52.8 58.4
HR 1.00 1.03 (0.90 - 1.19) 1.03 (0.89 - 1.19) 1.15 (0.99 - 1.33) 0.0812
Colon cancer, n 216 215 195 212
Incidence rate 27.7 28.5 29.6 33.3
HR 1.00 1.27 (1.02 - 1.50) 1.26 (1.03 - 1.54) 1.46 (1.20 - 1.78) 0.0003
Rectal cancer, n 228 222 183 189
Incidence rate 29.3 29.5 27.1 30.1
HR 1.00 1.10 (0.91 - 1.32) 1.04 (0.85 - 1.27) 1.14 (0.93 - 1.39) 0.2987
CI, confidence interval; HR, hazard ratio.
* Participants with any of the following features at study entry were excluded: missing data on leukocyte count, existing cancer, and
missing data on questionnaire.
The rate per 100,000 person-years is given, standardized to the age distribution of women in the 1995 Korean national population.
The Cox proportional hazards model was adjusted for age, BMI, total cholesterol, smoking status, regular exercise, alcohol consumption
per day (none, 0 - 29.9 g/day, 30 g/day), frequency of meat intake per week (nearly none, 1 - 2, 3), hypertension, and diabetes.
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Table 5. Age-adjusted Incidence Rate per 100,000 Person-years and Hazard Ratios for All Cancers, Colon Cancer, and
Rectal Cancer by WBC Quartile in Men, 1994-2003*
Quartile of WBC, cells/ Lμ
p value
for trend5500
(n = 18,611)
5501 - 6500
(n = 24,567)
6501 - 7600
(n = 28,018)
> 7600
(n = 37,711)
All cancers, n 1,950 2,505 2,816 4,014
Incidence rate 857.8 752.4 744.7 817.1
HR 1.00 0.98 (0.92 - 1.04) 0.96 (0.90 - 1.01) 1.02 (0.97 - 1.08) 0.2861
Colorectal cancer n 183 228 276 435
Incidence rate 89.8 59.8 78.1 83.6
HR 1.00 0.95 (0.78 - 1.15) 1.02 (0.84 - 1.23) 1.23 (1.03 - 1.47) 0.0030
Colon cancer, n 94 123 149 238
Incidence rate 43.2 31.7 42.0 49.2
HR 1.00 1.00 (0.76 - 1.31) 1.07 (0.83 - 1.39) 1.38 (1.09 - 1.76) 0.0017
Rectal cancer, n 111 130 157 232
Incidence rate 58.7 34.5 44.2 40.5
HR 1.00 0.91 (0.71 - 1.18) 0.99 (0.77 - 1.26) 1.16 (0.91 - 1.45) 0.0985
CI, confidence interval; HR, hazard ratio.
* Participants with any of the following features at study entry were excluded: missing data on leukocyte count, existing cancer, and
missing data on questionnaire.
The rate per 100,000 person-years is given, standardized to the age distribution of men in the 1995 Korean national population.
The Cox proportional hazards model was adjusted for age, BMI, total cholesterol, smoking status, regular exercise, alcohol consumption
per day (none, 0 - 29.9 g/day, 30 g/day), frequency of meat intake per week (nearly none, 1 - 2, 3), hypertension, and diabetes.
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We also assessed the association between WBC
and incidence of colon cancer after stratification
by smoking status (non-smokers, ex-smokers, and
current smokers) in order to confirm that the asso-
ciations were independent of the effects of
smoking on WBC.
Among men who reported having never smoked,
a positive linear trend was observed between the
incidence of colon cancer and WBC. The multi-
variate adjusted HRs for incidence of colon cancer
were 1.56 (95% CI 0.83-2.95), 2.61 (95% CI 1.45-
4.68), and 2.90 (95% CI 1.62-5.17) with increasing
WBC quartiles, compared with the reference quar-
tile (p for trend < 0.0001) (Fig. 1). A similar posi-
tive linear trend was also observed in female non-
smokers. The multivariate adjusted HRs for colon
cancer incidence were 1.27 (95% CI 1.04-1.55), 1.26
(95% CI 1.02-1.55), 1.47 (95% CI 1.19-1.81) with
increasing WBC quartiles, compared with the
reference quartile (p for trend = 0.0006) (Fig. 2).
However, there was no significant difference in
incidence of colon cancer among ex-smokers and
current smokers (Fig. 1, 2).
DISCUSSION
In this large prospective cohort study of Korean
men and women, a positive association between
WBC and the risk of colon cancer was found. Our
data suggest that an elevated WBC increases the
incidence risk and mortality of colon cancer in
men and women. These findings are consistent
with emerging evidence suggesting that inflam-
mation increases the risk of colon cancer. Indivi-
duals with long-term inflammatory bowel disease,
in particular ulcerative colitis, are at higher risk
for developing colorectal cancer than ordinary
individuals.10 A clinical trial demonstrated that
regular use of anti-inflammatory agents can re-
duce the risk of colorectal adenoma, a well-known
precancerous lesion.17 In a recent prospective
Fig. 1. Hazard ratios* for colon cancer in-
cidence by smoking status, 1994 - 2003 (*The
Cox proportional hazards model was adjusted
for age, BMI, total cholesterol, regular exercise,
alcohol consumption per day (none, 0 - 29.9 g/
day, 30 g/day), frequency of meat intake per
week (nearly none, 1 - 2, 3), hypertension,
and diabetes).
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cohort study examining the association between
WBC and the mortality risk of cancer, an elevated
WBC correlated with an increased mortality risk
for all cancers. However, the study failed to show
this association through subgroup analyses of
colon, breast, or prostate cancers.
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This may be
due to the lower number of deaths from the site-
specific cancers mentioned.
There are two previous prospective studies with
conflicting results on the relationship between
inflammatory markers and the incidence of colo-
rectal cancer. One study was a nested case-control
prospective study of 172 colorectal cases (131 co-
lon cases, 41 rectal cases) from the CLUE II cohort
of 22,887 residents from Washington County,
Maryland. In this study, the incidence risk of
colon cancer increased with CRP levels. However,
this association was not found in rectal cancer.13
In the other study, using 27,913 healthy women
within the Women's Health Study, high CRP
levels were not a predictive risk factor for the
development of colorectal cancer.14
Despite a positive association between WBC
and the incidence risk and mortality of colon can-
cer, we did not find a similarly significant asso-
ciation with rectal cancer in the present study. A
potential limitation of the CLUE II cohort study
is the relatively small number of rectal cancer
patients (n = 41), which could have weakened the
association between an elevated CRP level and the
incidence of rectal cancer. Our study overcomes
this weakness by conducting prospective follow-
ups on a larger number of rectal cancer patients
during a 10 year period. Our findings imply that
the role of inflammation in the development of
colon cancer may be different from that of rectal
cancer. The biological mechanisms through which
elevated WBC increases the risk of colon cancer
have not yet been established. However, several
plausible mechanisms between colon cancer and
inflammation deserve consideration based on
previous studies. Cyclooxygenase-2 (COX-2) may
Fig. 2. Hazard ratios* for colon cancer inci-
dence in women by smoking status, 1994-2003
(*The Cox proportional hazards model was
adjusted for age, BMI, total cholesterol, regular
exercise, alcohol consumption per day (none,
0-29.9 g/day, 30 g/day), frequency of meat
intake per week (nearly none, 1-2, 3), hyper-
tension, and diabetes).
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be linked to the pathogenesis of colon cancer.
COX-2 protein is over-expressed and prostaglan-
din E2 levels are elevated in the portal vein and
colonic mucosa in human colorectal cancers.19,20
COX-2 may control angiogenesis by modulating
production of the vascular endothelial growth
factor, which promotes sustained endothelial cell
proliferation and vascular permeability during
tumorogenesis.21,22 Many studies also demonstrate
that the carcinogenic effect of inflammation may
be linked to DNA damage in proliferative cells by
oxygen radicals,23 alteration of p53 tumor sup-
pressor gene,24 or inhibition of apoptosis.25 Dietary
and lifestyle risk factors for colon cancer, such as
a diet high in calories, animal fat and/or refined
carbohydrates, physical inactivity, central obesity,
and high body mass index are also related to in-
flammation and insulin resistance.26,27 Insulin
resistance may lead to tumor growth by elevating
bioavailable insulin growth factor-1 and decreasing
insulin growth factor binding protein-1.28 These
inflammatory effects on colon cancer may not
only be through systemic pathways, mediated by
cytokines and chemokines, but may also be
directly linked to the colonic epithelium. A recent
study shows that individuals with more risk
factors for colorectal cancer have a higher level of
calprotectin, which is a marker of bowel inflam-
mation at the tissue level.29
Our study has several potential limitations.
First, WBCs during the 10 year follow-up were
not available for our study. Thus, only one mea-
surement of WBC, at baseline examination, was
included in the analysis. Therefore, it was not
possible to determine whether an acute, brief
episode of inflammation or chronic inflammation
was responsible for the correlation found in the
current study. Second, data on potentially con-
founding factors, such as a history of inflamma-
tory bowel disease, colorectal polyps, or medicinal
use (aspirin, other NSAIDs, or estrogen use) were
unavailable in the baseline questionnaire. These
variables are not fully adjusted in our Cox-propor-
tional hazards regression model. Lastly, the cohort
population, particularly the older population,
might not be representative of the general Korean
population.
Despite these potential limitations, the current
study has several important strengths. First, our
study is a large prospective study with a relatively
long follow-up period, so we can be confident
about the temporal relationship between inflam-
mation and the risk of colon cancer. Second, this
positive association was sustained even after ex-
cluding cases of colon cancer that developed with-
in the first 2 years of follow-up, thereby reducing
the likelihood of a subclinical cancer at baseline.
Consequently, elevated WBC was unlikely to be
caused and biased by subclinical colon cancer.
Finally, similar positive trends observed in non-
smokers suggest that the incidence risk of colon
cancer, associated with an elevated WBC, is
independent of the effects of smoking on WBC.
In conclusion, our findings demonstrate that
elevated WBC is a predictor of the incidence risk
and mortality of colon cancer. These results sup-
port our hypothesis that inflammation increases
the risk of colon cancer. Further observational and
experimental studies are needed to confirm these
findings and to determine the role of inflamma-
tion in the carcinogenesis of colon and rectal
cancer.
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